無料プレビュー

Viatris Inc. (VTRS) · NASDAQ Global Select

プロフィール

Viatris is a global pharmaceutical company that manufactures and distributes branded drugs, generic medicines, and complex products across more than 165 countries. The company supplies high-quality medicines to approximately 1 billion patients annually through a portfolio of over 1,400 approved molecules and iconic brands. Viatris operates through four geographic segments—Developed Markets, Greater China, JANZ, and Emerging Markets—leveraging its 27 manufacturing and distribution sites worldwide and global commercial, R&D, regulatory, and medical expertise.

主要指標

株価: $17.44 (-0.29%)
時価総額: 203億ドル
PER（今期予想）: 6.9
PBR: 1.4
配当利回り: 2.75%
52週レンジ: $9.69 – $18.43
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: NASDAQ Global Select
構成銘柄: S&P 500 0.03%

比較会社: TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、RDY Dr. Reddy's Laboratories Limited、ALKS Alkermes plc、AMRX Amneal Pharmaceuticals, Inc.、OGN Organon & Co.、BHC Bausch Health Companies Inc.、ANIP ANI Pharmaceuticals, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-05 · 更新: 2026-10-08